下面几页是对它的视觉化表现，52周肾脏应答的呈现，这个是跟上一页是一样

The following pages are the visual representation of it, showing the 52-week renal response. This is the same as the previous page. Compared with the control group, the gray is the control group. This page is the secondary endpoint, the renal response at 24 weeks, Voclosporin in red, and control in gray, 32.4 to 19.7. This page is the secondary endpoint UPCR is less than or equal to 0.5 mg, the horizontal axis is time in days, the vertical axis is the probability of less than or equal to 0.5, red is Voclosporin, and purple is the placebo control group. This page is over time, he corrected EGFR and serum creatinine. The red is Voclosporin and the purple is the control group. This page is for the subjects to adjust the dose, and this page is for the differentiation of response rates by race. This page is about systolic and diastolic blood pressure, and it concludes that there is no statistical difference. The last page is a summary of adverse events. This is all its data. Do you see these data and introduction clearly? <br>1: Not bad.

The following pages are a visual manifestation of it, a 52-week renal response, which is the same as the previous page, and gray is the control group compared to the control group. This page was the secondary end, 24 weeks of kidney response, red with Voclosporin, gray with control group, 32.4 to 19.7. This page is the secondary endpoint UPCR is less than or equal to 0.5 mg, the horizontal axis is time is day, the vertical axis is less than or equal to 0.5 probability, red is Voclosporin, purple is the placebo control group. This page is over time as he corrects the condition of EGFR and serum creatinine. The red one is Voclosporin, and the purple is the control group. This page is the dose adjustment required by the subjects, and this page is divided by the response rate of the person. This page is the case of systolic and espressopressury, and it concludes that there is no statistical difference. This last page is a summary of bad events. This is all its data. Do you see the data and the introduction clearly?<br>1: OK.

The next few pages are the visualization of it, the presentation of renal response at 52 weeks. This is the same as the previous page. Compared with the control group, gray is the control group. This page is the secondary endpoint, 24 weeks of renal response, the red one is voclosporin, and the gray is the control group, 32.4 vs. 19.7. This page shows the secondary end point of upcr less than or equal to 0.5 mg, the horizontal axis is the time of day, the vertical axis is the probability of less than or equal to 0.5, the red is voclosporin, and the purple is the placebo control group. This page is about his revision of EGFR and serum creatinine over time. The red one is voclosporin, and the purple one is the control group. This is a page of patient response that needs to be adjusted according to the dose rate. This page is about systolic and diastolic blood pressure, and it concludes that there is no statistical difference. The last page is a summary of the adverse events. This is all its data. Are you clear about the data and introduction?<br>1: Not bad.<br>